A topological substructural approach for the prediction of P-glycoprotein substrates

被引:54
作者
Cabrera, MA [1 ]
González, I
Fernández, C
Navarro, C
Bermejo, M
机构
[1] Cent Univ Las Villas, Ctr Chem Bioact, Dept Drug Design, Santa Clara 54830, Villa Clara, Cuba
[2] Univ Valencia, Dept Pharm & Pharmaceut Technol, E-46100 Valencia, Spain
关键词
TOPS-MODE; P-glycoprotein; P-gp; molecular modeling; in silico; QSAR;
D O I
10.1002/jps.20449
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A topological substructural molecular design approach (TOPS-MODE) has been used to predict whether a given compound is a P-glycoprotein (P-gp) substrate or not. A linear discriminant model was developed to classify a data set of 163 compounds as substrates or nonsubstrates (91 substrates and 72 nonsubstrates). The final model fit the data with sensitivity of 82.42% and specificity of 79.17%, for a final accuracy of 80.98%. The model was validated through the use of an external validation set (40 compounds, 22 substrates and 18 nonsubstrates) with a 77.50% of prediction accuracy; fivefold full cross-validation (removing 40 compounds in each cycle, 80.50% of good prediction) and the prediction of an external test set of marketed drugs (35 compounds, 71.43% of good prediction). This methodology evidenced that the standard bond distance, the polarizability and the Gasteiger-Marsilli atomic charge affect the interaction with the P-gp; suggesting the capacity of the TOPS-MODE descriptors to estimate the P-gp substrates for new drug candidates. The potentiality of the TOPS-MODE approach was assessed with a family of compounds not covered by the original training set (6-fluoroquinolones), and the final prediction had a 77.7% of accuracy. Finally, the positive and negative substructural contributions to the classification of 6-fluoroquinolones, as P-gp substrates, were identified; evidencing the possibilities of the present approach in the lead generation and optimization processes. (c) 2006 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:589 / 606
页数:18
相关论文
共 61 条
[1]   VAN DER WAALS VOLUMES + RADII [J].
BONDI, A .
JOURNAL OF PHYSICAL CHEMISTRY, 1964, 68 (03) :441-+
[2]   Polarizability fields for use in three-dimensional quantitative structure-activity relationship (3D-QSAR) [J].
Bradley, M ;
Waller, CL .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2001, 41 (05) :1301-1307
[3]  
Burkert U., 1982, Molecular Mechanics
[4]   TOPS-MODE approach for the prediction of blood-brain barrier permeation [J].
Cabrera, MA ;
Bermejo, M ;
Pérez, M ;
Ramos, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (07) :1701-1717
[5]   COLLATERAL SENSITIVITY OF MULTIDRUG-RESISTANT CELLS TO NARCOTIC ANALGESICS IS DUE TO EFFECTS ON THE PLASMA-MEMBRANE [J].
CALLAGHAN, R ;
RIORDAN, JR .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1236 (01) :155-162
[6]   Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors [J].
Cormet-Boyaka, E ;
Huneau, JF ;
Mordrelle, A ;
Boyaka, PN ;
Carbon, C ;
Rubinstein, E ;
Tomé, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2607-2611
[7]   Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates [J].
Dautrey, S ;
Felice, K ;
Petiet, A ;
Lacour, B ;
Carbon, C ;
Farinotti, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (07) :1728-1734
[8]   In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin [J].
de Lange, ECM ;
Marchand, S ;
van den Berg, DJ ;
van der Sandt, ICJ ;
de Boer, AG ;
Delon, A ;
Bouquet, S ;
Couet, W .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (02) :85-93
[9]   Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs [J].
Doan, KMM ;
Humphreys, JE ;
Webster, LO ;
Wring, SA ;
Shampine, LJ ;
Serabjit-Singh, CJ ;
Adkison, KK ;
Polli, JW .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) :1029-1037
[10]   Progress in predicting human ADME parameters in silico [J].
Ekins, S ;
Waller, CL ;
Swaan, PW ;
Cruciani, G ;
Wrighton, SA ;
Wikel, JH .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 44 (01) :251-272